S

SecureBio

Non-profit advancing biosecurity research and policy

Senior Research Scientist - AI Biosecurity Assessments

AI ResearchConfirmed live in the last 24 hours
Full-timeRemote in USA$235k - $300k

About the Job

Requirements

  • A PhD in pathogen biology, microbiology, virology, or a closely related field is required; equivalent depth from other paths may be considered.
  • Use strategic judgment to assess how evaluation results map onto real-world biological risk and where technical safeguards succeed or fail.
  • Have a deep interest in safeguards and their failure modes, alongside contributory biological capabilities.
  • Turn complex technical results into clear, well-structured writing.
  • Be comfortable with short, intensive project cycles and shifting priorities as new models are released.

Responsibilities

  • Work with AI firms and internal research and engineering teams to conduct capability and safeguard assessments of emerging AI models.
  • Execute evaluation pipelines, analyze data, and identify how results align with relevant threat models and risk levels.
  • Manually assess models for willingness and knowledge across specialized domains of biology.
  • Synthesize findings into clear evaluation reports, technical write-ups, and risk summaries for partners and regulatory bodies.
  • Contribute to papers, reports, and the public dashboard of capability trends.

Desired Qualifications

  • Wet-lab experience.
  • Approximately one year of coding in an industry or graduate research setting, and working fluency in Python.
  • Direct experience with the Inspect AI framework, or with building and evaluating large language model or agent systems more broadly.
  • Familiarity with biosecurity policy, threat assessment, or counterterrorism work.
  • Experience working with AI developers, or in a regulated or nondisclosure-agreement-heavy environment.

About the Company

SecureBio

Non-profit advancing biosecurity research and policy

SecureBio is a non-profit that reduces the risk of catastrophic pandemics by combining technology development with policy work through a Delay, Detect, Defend framework. Its tools include DNA-synthesis screening software to slow the spread of dangerous biotechnologies (Delay), and the Nucleic Acid Observatory, which uses untargeted metagenomic sequencing as an early warning system for new threats (Detect). It differentiates itself by pairing in-house research with real-world policy and risk assessment efforts, collaborating with academia, industry, and government, and by running programs like the AIxBio risk evaluation suite and the SecureDNA screening foundation to broaden access to biosurveillance. Its goal is to make society more resilient to biological risks by preventing misuse, early detecting emerging threats, and improving defensive measures such as affordable PPE and safe biotechnologies.

Company size
11-50
Company stage
Not listed
Total funding
Not listed
Headquarters
Cambridge, MA
Founded
Not listed

Recently Posted Jobs

Explore more opportunities at SecureBio

See more jobs